Joseph Michael Fitzgerald Boston Scientific Corp (BSX) insider trading activity

Joseph Michael Fitzgerald is EVP & Group Pres, Cardiology of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 174,746 shares of BSX, which is worth approximately $18.5 Million. The most recent transaction as insider was on Feb 12, 2025, when has been sold 1,579 shares (Common Stock) at a price of $105.77 per share, resulting in proceeds of $167,010. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 175K

8.9% 3M change

7.48% 12M change

Total Value Held $18.5 Million

Joseph Michael Fitzgerald Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2025	SELL Payment of exercise price or tax liability	$167,010 $105.77 p/Share	1,579 Reduced 0.9%	174,746 Common Stock
Feb 12 2025	BUY Exercise of conversion of derivative security	-	3,462 Added 1.93%	176,325 Common Stock
Feb 11 2025	SELL Payment of exercise price or tax liability	$1,531,093 $105.98 p/Share	14,447 Reduced 7.71%	172,863 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	31,680 Added 14.47%	187,310 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$573,881 $89.32 p/Share	6,425 Reduced 3.97%	155,600 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	13,907 Added 7.9%	162,025 Common Stock
Dec 10 2024	SELL Open market or private sale	$1,799 $89.97 p/Share	20 Reduced 0.01%	148,148 Common Stock
Dec 03 2024	BUY Open market or private purchase	$4,514 $90.29 p/Share	50 Added 0.03%	148,168 Common Stock
Nov 26 2024	SELL Bona fide gift	-	11,236 Reduced 7.05%	148,118 Common Stock
Nov 25 2024	SELL Bona fide gift	-	1,113 Reduced 0.69%	159,354 Common Stock
Oct 07 2024	SELL Open market or private sale	$11,264,795 $85.0 p/Share	132,527 Reduced 45.23%	160,467 Common Stock
Oct 07 2024	BUY Exercise of conversion of derivative security	$2,463,415 $21.12 p/Share	116,639 Added 28.47%	292,994 Common Stock
Aug 28 2024	SELL Open market or private sale	$1,130,560 $80.0 p/Share	14,132 Reduced 7.42%	176,355 Common Stock
May 13 2024	SELL Bona fide gift	-	2,380 Reduced 1.23%	190,487 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$120,384 $65.82 p/Share	1,829 Reduced 0.94%	192,867 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	3,706 Added 1.87%	194,696 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$135,391 $65.82 p/Share	2,057 Reduced 1.07%	190,990 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	4,167 Added 2.11%	193,047 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$118,870 $65.82 p/Share	1,806 Reduced 0.95%	188,880 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	3,960 Added 2.03%	190,686 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$131,240 $65.95 p/Share	1,990 Reduced 1.05%	186,726 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	4,362 Added 2.26%	188,716 Common Stock
Feb 12 2024	SELL Bona fide gift	-	6,000 Reduced 3.15%	184,354 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	16,450 Reduced 7.95%	190,354 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	33,332 Added 13.88%	206,804 Common Stock

JMF

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account